ProBiotix Health Plc (PBX.AQSE) Share Price & News
Bid
--
-
Ask
- High-
- OPEN-
- VOL-
- MKT CAP-M
- LOW-
- CLOSE-
- SHARES IN ISSUE121.67M
ProBiotix Health Plc Company Profile
ProBiotix develops probiotics (live microbes that, when ingested, can alter the composition of the microbiome, and improve human health) to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. ProBiotix’s cholesterol reducing probiotic, Lactobacillus plantarum ECGC13110402 (“LP-LDL®), is manufactured in pharmaceutical GMP-certified facilities and protected worldwide by in the region of 5 patent families, comprising 27 patents and pending patent applications, and 22 trademarks.